|
Quotes & Info
|
| DVAX > SEC Filings for DVAX > Form 8-K on 3-Jun-2009 | All Recent SEC Filings |
3-Jun-2009
Other Events, Financial Statements and Exhibits
On June 3, 2009, Dynavax Technologies Corporation (Dynavax) issued a press release titled "Dynavax Presents Additional Phase 3 Data for HEPLISAV(TM) Hepatitis B Vaccine at DDW Medical Conference." A copy of the press release is attached as Exhibit 99.1 to this current report and is incorporated herein by reference.
(d) Exhibit
Exhibit No. Description
99.1 Press Release, dated June 3, 2009, titled "Dynavax Presents Additional
Phase 3 Data for HEPLISAV(TM) Hepatitis B Vaccine at DDW Medical Conference."
|
|